PASADENA: A Randomized, Double-Blind, PlaceboControlled, 52-Week Phase II Study to Evaluate the Efficacy of Intravenous RO7046015 (PRX002) in…
An Open-Label Extension of Study M15-741 to Evaluate the Safety and Tolerability of 24-Hour Daily Exposure to Continuous Subcutaneous Infusion of…
This is an observational research study to better understand Parkinson's Disease (PD).
Seeking progress to potentially help slow disease progression for people with early-stage Parkinson's Disease.
You or your loved one who has been diagnosed with Parkinson's disease may be interested in participating in one of the TemPo Studies.
A 27 Week Phase 3, Double-blind, Placebo-controlled Trial to evaluate Tavapadon for PD in Levodopa treatment adults with motor fluctuations.  Open…
The purpose of this study, which involved research, is to determine if investigational treatment, JM-010, is safe and effective in the treatment of…
To understand the best treatment options for youth with type 2 diabetes and the complications related to early onset type 2 diabetes.
Eligibility…
Study Goal(s): To mitigate health disparities by addressing social needs and behavioral health early in the course of type 1 diabetes. …
Study Goal(s): This randomized control trial is testing a resilience-building skills program for adolescents with T1D and elevated diabetes distress…